The Lancet· 2014
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
- 660citations
- 2014year
Short summary
Latanoprost eye drops significantly preserved visual fields in open-angle glaucoma patients over 24 months compared to placebo, with an adjusted hazard ratio of 0.44 (p=0.0003).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Ophthalmology
OphthalmologyMedicine